What is Cartalax?
Cartalax is a Khavinson bioregulator peptide targeting cartilage and connective tissue. Studied for normalisation of chondrocyte gene expression, collagen production, and age-related cartilage decline. Used in osteoarthritis and joint longevity research models. Research use only.
Research Applications
Chondrocyte Biology
Proliferation, collagen II expression, proteoglycan synthesis
Cartilage Geroprotection
Age-related chondrocyte senescence, ECM degradation inhibition
Collagen Synthesis Studies
Type I/II collagen expression, fibroblast activation, ECM organisation
Joint & Osteoarthritis Models
Cartilage degradation scoring, inflammatory cytokines, MMP inhibition
Connective Tissue Repair
Tendon and ligament fibroblasts, tissue remodelling, growth factor interaction
Quick Specs
| Form | Ala-Glu-Asp-Gly tetrapeptide analogue |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | N/A — proprietary tripeptide |
| Molecular Weight | MS molecular weight confirmed — every batch |
| Specification | ≥99% by HPLC — every batch |
| Shelf Life | 24 months (unopened) |
| Storage | -20°C sealed | 2–8°C reconstituted (4 weeks) |
| Manufacture | In-house Fmoc SPPS — Qingdao, China |
| Brand | Anti-Aging & Longevity |